Effects of alendronate on a disintegrin and metalloproteinase with thrombospondin motifs expression in the developing epiphyseal cartilage in rats

Journal of Veterinary Medicine Series C: Anatomia Histologia Embryologia

Volumn 38, Issue 2, 2009, Pages 154-160

  Kim, M S ^a   Kim, J H ^a   Lee, M R ^a   Kang, J H ^a   Kim, H J ^a,b   Ko, H M ^a   Choi, C H ^a   Jung, J Y ^a   Koh, J T ^a   Kim, B K ^a   Oh, H K ^a   Kim, W J ^a   Lee, E J ^a   Kim, S H ^a  

^a Chonnam National University   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT; DISINTEGRIN; MESSENGER RNA; METALLOPROTEINASE; THROMBOSPONDIN;

ANIMAL; ARTICLE; CARTILAGE CELL; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GROWTH PLATE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NEWBORN; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

AGGRECANS; ALENDRONATE; ANIMALS; ANIMALS, NEWBORN; BONE DENSITY CONSERVATION AGENTS; CELLS, CULTURED; CHONDROCYTES; DISINTEGRINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROWTH PLATE; METALLOENDOPEPTIDASES; METALLOPROTEASES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THROMBOSPONDINS;

RATTUS;

EID: 62349097525     PISSN: 03402096     EISSN: 14390264     Source Type: Journal    
DOI: 10.1111/j.1439-0264.2008.00920.x     Document Type: Article

References (51)

1. Arner, E. C., C. E. Hughes, C. P. Decicco, B. Caterson M. D. Tortorella, 1998 : Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase. Osteoarthritis Cartilage 6, 214 228.
2. Barrett, A. J., 1994 : Classification of peptidases. Methods Enzymol. 244, 1 15.
3. Cawston, T., C. Billington, C. Cleaver, S. Elliott, W. Hui, P. Koshy, B. Shingleton A. Rowan, 1999 : The regulation of MMPs and TIMPs in cartilage turnover. Ann. N. Y. Acad. Sci. 878, 120 129.
4. Colige, A., I. Vandenberghe, M. Thiry, C. A. Lambert, J. Van Beeumen, S. W. Li, D. J. Prockop, C. M. Lapiere B. V. Nusgens, 2002 : Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3. J. Biol. Chem. 277, 5756 5766.
5. Curtis, C. L., C. E. Hughes, C. R. Flannery, C. B. Little, J. L. Harwood B. Caterson, 2000 : n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J. Biol. Chem. 275, 721 724.
6. Dean, D. D., O. E. Muniz D. S. Howell, 1989 : Association of collagenase and tissue inhibitor of metalloproteinases (TIMP) with hypertrophic cell enlargement in the growth plate. Matrix 9, 366 375.
7. Dean, D. D., O. E. Muniz, J. F. Woessner Jr. D. S. Howell, 1990 : Production of collagenase and tissue inhibitor of metalloproteinases (TIMP) by rat growth plates in culture. Matrix 10, 320 330.
8. Descalzi Cancedda, F., A. Melchiori, R. Benelli, C. Gentili, L. Masiello, G. Campanile, R. Cancedda A. Albini, 1995 : Production of angiogenesis inhibitors and stimulators is modulated by cultured growth plate chondrocytes during in vitro differentiation: dependence on extracellular matrix assembly. Eur. J. Cell Biol. 66, 60 68.
9. Felson, D. T. Y. J. Kim, 2007 : The futility of current approaches to chondroprotection. Arthritis Rheum. 56, 1378 1383.
10. Fernandes, R. J., S. Hirohata, J. M. Engle, A. Colige, D. H. Cohn, D. R. Eyre S. S. Apte, 2001 : Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J. Biol. Chem. 276, 31502 31509.
11. Flannery, C. R., M. W. Lark J. D. Sandy, 1992 : Identification of a stromelysin cleavage site within the interglobulin domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. J. Biol. Chem. 267, 1008 1014.
12. Fosang, A. J., P. J. Neame, K. Last, T. E. Hardingham, G. Murphy J. A. Hamilton, 1992 : The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J. Biol. Chem. 7, 19470 19474.
13. Fosang, A. J., K. Last, V. Knäuper, P. J. Neame, G. Murphy, T. E. Hardingham, H. Tschesche J. A. Hamilton, 1993 : Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem. J. 295, 273 276.
14. Fosang, A. J., K. Last, V. Knäuper, G. Murphy P. J. Neame, 1996 : Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 380, 17 20.
15. Garnero, P., S. Christgau P. D. Delmas, 2001 : The bisphosphonate zolendronate decreases type II collagen breakdown in patients with Paget's disease of bone. Bone 28, 461 464.
16. Glasson, S. S., R. Askew, B. Sheppard, B. Carito, T. Blanchet, H. L. Ma, C. R. Flannery, D. Peluso, K. Kanki, Z. Yang, M. K. Majumdar E. A. Morris, 2005 : Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644 648.
17. Gumienna-Kontecka, E., J. Jezierska, M. Lecouvey, Y. Leroux H. Kozlowski, 2002 : Bisphosphonate chelating agents. Coordination ability of 1-phenyl-1-hydroxymethylene bisphosphonate towards Cu(2+) ions. J. Inorg. Biochem. 89, 13 17.
18. Hardingham, T. E. A. J. Fosang, 1992 : Proteoglycans-many forms and functions. FASEB J. 6, 861 870.
19. Hashimoto, G., T. Aoki, H. Nakamura, K. Tanzawa Y. Okada, 2001 : Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett. 494, 192 195.
20. Hayami, T., M. Pickarski, G. A. Wesolowski, J. Mclane, A. Bone, J. Destefano, G. A. Rodan L. T. Duong, 2004 : The role of subchondral bone remodelling in osteoarthritis - reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum. 50, 1193 1206.
21. Jones, G. C. G. P. Riley, 2005 : ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res. Ther. 7, 160 169.
22. Kashiwagi, M., M. Tortorella, H. Nagase K. Brew, 2001 : TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAMTS-4) and aggrecanase 2 (ADAMTS-5). J. Biol. Chem. 276, 12501 12504.
23. Kevorkian, L., D. A. Young, C. Darrah, S. T. Donell, L. Shepstone, S. Porter, S. M. Brockbank, D. R. Edwards, A. E. Parker I. M. Clark, 2004 : Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum. 50, 131 141.
24. Kuno, K., Y. Okada, H. Kawashima, H. Nakamura, M. Miyasaka, H. Ohno K. Matsushima, 2000 : ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett. 478, 241 245.
25. Lark, M. W., J. T. Gody, J. R. Weidner, J. Ayaia, J. H. Kimura H. R. Williams, 1995 : Cell-mediated catabolism of aggrecan. Evidence that cleavage at the 'aggrecanase' site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain. J. Biol. Chem. 270, 2550 2556.
26. Lehmann, H. J., U. Mouritzen, S. Christgau, P. A. Clos C. Christiansen, 2002 : Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann. Rheum. Dis. 61, 530 533.
27. Lohmander, L. S., P. J. Neame J. D. Sandy, 1993 : The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 36, 1214 1222.
28. Mankin, H. J. L. Lipiello, 1970 : Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. J. Bone Joint Surg. 52, 210 215.
29. Matsuo, A., T. Shuto, G. Hirata, H. Satoh, Y. Matsumoto, H. Zhao Y. Iwamoto, 2003 : Antiinflammatory and chondroprotective effects of the aminobisphosphonate incarronate(YM175) in adjuvant induced arthritis. J. Rheumatol. 30, 1280 1290.
30. Muehleman, C., J. Green, J. M. Williams, K. E. Kuettner, E. M. J. A. Thonart D. R. Sumner, 2002 : The effect of bone remodeling inhibition by zolendronic acid in an animal model of cartilage matrix damage. Osteoarthritis Cartilage 10, 226 233.
31. Nagase, H. M. Kashiwagi, 2003 : Aggrecanases and cartilage matrix degradation. Arthritis Res. Ther. 5, 94 103.
32. Pelletier, J. P., D. Lajeunesse, D. V. Jovanovic, V. Lascau-Coman, F. C. Jolicoeur, G. Hilal, J. C. Fernandes J. Martel-Pelletier, 2000 : Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. J. Rheumatol. 27, 2893 2902.
33. Plaas, A., B. Osborn, Y. Yoshihara, Y. Bai, T. Bloom, F. Nelson, K. Mikecz J. D. Sandy, 2007 : Aggrecanolysis in human osteoarthritis: confocal localization and biochemical characterization of ADAMTS5-hyaluronan complexes in articular cartilages. Osteoarthritis Cartilage 15, 719 734.
34. Pratta, M. A., W. Yao, C. Decicco, M. D. Tortorella, R. Q. Liu, R. A. Copeland, R. Ronald, R. M, R. C. Newton, J. M. Trzaskos E. C. Arner, 2003 : Aggrecan protects cartilage collagen from proteolytic cleavage. J. Biol. Chem. 278, 45539 45545.
35. Prockop, D. J., 1998 : What holds us together? Why do some of us fall part? What can we do about it? Matrix Biol. 16, 519 528.
36. Sandy, J. D., 2006 : A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis Cartilage 14, 95 100.
37. Sandy, J. D., P. J. Neame, P. L. Boynton C. R. Flannery, 1991 : Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J. Biol. Chem. 266, 8683 8685.
38. Somerville, R. P., S. A. Oblander S. S. Apte, 2003 : Matrix metalloproteinases: old dogs with new tricks. Genome Biol. 4, 216 226.
39. Song, R., M. D. Tortorella, A. Malfait, J. T. Alston, Z. Yang, E. C. Arner D. W. Griggs, 2007 : Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum. 56, 575 585.
40. Spector, T. D., P. G. Conaghan, J. C. Buckland-Wright, P. Garnero, G. A. Cline, J. F. Beary, D. J. Valet J. M. Meyer, 2005 : Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial. Arthritis Res. Ther. 7, R625 R633.
41. Stanton, H., F. M. Rogerson, C. J. East, S. B. Golub, K. E. Lawlor, C. T. Meeker, C. B. Little, K. Last, P. J. Farmer, I. K. Campbell, A. M. Fourie A. J. Fosang, 2005 : ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434, 648 652.
42. Sternlicht, M. D. Z. Werb, 2001 : How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463 516.
43. Stewart, M. C., A. J. Fosang, Y. Bai, B. Osborn, A. Plaas J. D. Sandy, 2006 : ADAMTS5-mediated aggrecanolysis in murine epiphyseal chondrocyte cultures. Osteoarthritis Cartilage 14, 392 402.
44. Thirunavukkarasu, K., Y. Pei, T. L. Moore, H. Wang, X. P. Yu, A. G. Geiser S. Chandrasekhar, 2006 : Regulation of the human ADAMTS-4 promoter by transcription factors and cytokines. Biochem. Biophys. Res. Commun. 345, 197 204.
45. Tortorella, M., M. Pratta, R. Q. Liu, I. Abbaszade, H. Ross, T. Burn E. Arner, 2000 : The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J. Biol. Chem. 275, 25791 25797.
46. Tortorella, M. D., E. C. Arner, R. Hills, J. Gormley, K. Fok, L. Pegg L, G. Munie A. M. Malfait, 2005 : ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms. Arch. Biochem. Biophys. 444, 34 44.
47. Vazquez, F., G. Hastings, M. A. Ortega, T. F. Lane, S. Oikemus, M. Lombardo M. L. Iruela-Arispe, 1999 : METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J. Biol. Chem. 274, 23349 23357.
48. Verdrengh, M., H. Carlsten, C. Ohlsson A. Tarkowski, 2007 : Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. J. Orthop. Res. 25, 304 310.
49. Vu, T. H., J. M. Shipley, G. Bergers, J. E. Berger, J. A. Helms, D. Hanahan, S. D. Shapiro, R. M. Senior Z. Werb, 1998 : MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411 422.
50. Werb, Z. J. R. Chin, 1998 : Extracellular matrix remodelling during morphogenesis. Ann. N. Y. Acad. Sci. 857, 110 118.
51. Wight, T. N., 2005 : The ADAMTS proteases, extracellular matrix, and vascular disease: waking the sleeping giant(s) Arterioscler. Thromb. Vasc. Biol. 25, 12 14.